The Ecraid 2025 Annual Report reflects on a year of important milestones, with highlights from our research and education activities. A balanced reflection, celebrating our achievements while sharing what we learned from the challenges we faced. Discover it here: drive.proton.me/u/0/3r3ZZUJd...

#Education is an essential tool for advancing clinical research in ID and AMR. At Ecraid, learning is embedded in a European network, connecting education with research & collaboration. 👉🏽Discover the Ecraid x ESCMID Postgraduate Course in Verona and meet our experts: bit.ly/48jUgdg

Pandemic preparedness begins before a crisis arises. Yazdan Yazdanpanah explains why “ever-warm” research & clinical networks are essential for responding to emerging threats. 🦠 Strong partnerships & ongoing collaboration are helping build a more resilient future. 👉🏽Read how: bit.ly/Expert_Yazdan

Behind every trial result: dedication, commitment & collaboration. The SNAP Trial unites 150+ hospitals in 14+ countries to tackle one of the most serious bloodstream infections. Its impact comes from experts & partnerships driving coordinated, high-impact research for patient care: bit.ly/SNAPTrial

📩 Our latest newsletter is out! Discover: Verona methodology course, ECRAID‑Prime milestone, pandemic preparedness across Europe & contribution to the WHO NAVIS protocol for Hantavirus, STRIDE‑CAP vaccine study, and Ecraid's 2027 Science Meeting. 👉🏽Stay informed—subscribe now: bit.ly/news-june-26

💡 New publication - scientific correspondence in BMC Critical Care on #VAP epidemiology! The complete scientific dialogue - including the original manuscript, peer commentary, and authors' response - is available here 🔗 bit.ly/4w2xkZA #ClinicalEpidemiology #InfectiousDiseases #VAP #STATNet

Save the Date: Ecraid Foundation Science Meeting 2027, Verona (2–3 Feb). Join Europe’s infectious diseases & AMR community. Partners from academia, healthcare, industry, and public health will share insights, collaborate, and shape future research. Details to follow. For info: [email protected]

📣 Practice-changing data published in both the NEJM and The Lancet! The #SNAPTrial results are set to redefine international guidelines for treating golden #Staph bloodstream infections. Ecraid is proud to be a European partner for this landmark study. #PatientSafety #AdaptiveTrials #StaphAureus

Effective outbreak response depends on networks built in peacetime. Ecraid CEO @lenniederde.bsky.social highlights that pandemic readiness comes from sustained collaboration. Strong partnerships, like BeReady, enable rapid, coordinated public health action. Check interview: bit.ly/ecraidpandem...

We're proud to have contributed to this framework, which is demonstrating its vital role in the coordinated global research response to the AHV outbreak. Embedding high-quality observational research directly into emergency operations is a significant step forward. Learn more bit.ly/4a2MtSh

The 3-day postgraduate course is designed for researchers using epidemiological and statistical methods, and bridges advanced theory with hands-on project mentorship. Why Attend? 👇🏻 📋 Cutting-edge Curriculum 📝 Publishing Excellence 👩🏻‍🏫 Bespoke Workshops www.escmid.org/event-detail...

Ecraid and @esicm.bsky.social are strengthening collaboration to advance intensive care research, education, & pandemic preparedness across Europe. CEO @lenniederde.bsky.social supports Surviving Sepsis Campaign updates & joins ESICM’s webinar on patient perspectives. Click on the link to attend 👇🏽

Happy to share two recent Ecraid publications from our colleagues - congratulations! Risk score for VAP: www.sciencedirect.com/science/arti... Pneumococcal vaccines: publications.ersnet.org/content/erjo... For an overview of Ecraid publications visit our Resources page: ecraid.eu/driving-prog...

🦠Pandemic preparedness isn't built during a crisis but in the quiet periods in between. Preparedness requires a warm-base network that is already connected. This is exactly what Ecraid maintains. 👉🏽Connect with the experts behind it: bit.ly/Ecraid-Connect #PandemicPreparedness #ClinicalTrials

📩Our May Newsletter is out! Discover updates on the new ECRAID Clinical Liaison Council Chair and Vice-Chair, key ECRAID-Prime trial milestones, recent publications, and upcoming courses! 🔍Read more: bit.ly/may26ecraid 👉🏽Subscribe to stay informed each month! #InfectiousDiseases #ClinicalResearch

The ECRAID-Prime #adaptiveplatformtrial is a first-of-its-kind multinational study in community care using decentralised trial elements. Read the key learnings & experiences on meaningful #patientinvolvement to strengthen clinical trials in #publichealth emergencies. 👉🏼 www.ecraid.eu/news/ecraid-...

Ecraid and @esicm.bsky.social announce a strategic partnership to strengthen #ICU research, education, & pandemic preparedness across Europe. Together we’ll expand networks, drive joint studies, co-develop training on infections, sepsis, AMR & crisis preparedness. 👉🏽More info: bit.ly/esicm-ecraid

Today on #KangarooCareAwarenessDay 🦘, we’re proud to support @pentafoundation.bsky.social in raising awareness of kangaroo care. Ecraid is proud to contribute to the #NeoDeco study, exploring how optimised kangaroo care may help reduce #NeonatalInfections and #Sepsis in preterm infants in #NICUs. 🩺

Emerging threats like #Hantavirus require a warm-based, unified response. Ecraid works at the heart of the #BEREADY partnership to connect clinical sites with global stakeholders and national authorities. Together with our partners, we stand ready. #PandemicPreparedness #InfectiousDiseases

🙌🏽 Pleased to share that the #ECRAIDPrime LTX-109 study has achieved its recruitment target! 🧪Read more about this EU-funded trial and Phase 2A study on the LTX-109 compound, developed by Pharma Holdings on lnkd.in/eHR28vr9.

Join this 5th edition of our postgraduate course 👉 bit.ly/48jUgdg The programme is not limited to ID specialists; we welcome clinical researchers from all disciplines, epidemiologists, and public health professionals seeking to elevate their study design and evidence generation skills.

Our April newsletter is live! 🔬 Highlights from ESCMID Global 2026 🎓 PG course in Verona now open for registration 🤝🏽 New global partnerships driving innovation in clinical research Stay informed—subscribe for monthly updates: bit.ly/EcraidNewsAp... #InfectiousDiseases #ClinicalResearch #Education

We were pleased to host a successful #SNAPTrial Investigator Meeting at #ESCMIDGlobal2026. Last Tuesday’s session brought together Chief Investigators from across Europe, as well as our Coordinating Chief Investigators from Australia, who provided a valuable global perspective & progress updates.

Wrapping up day 1 at #ESCMIDGlobal2026 not a full stop, just a comma. Great discussions with colleagues & partners, all focused on advancing #InfectiousDiseases research & preparedness. Thanks to everyone who joined our sessions & stopped by. Strong start, round two tomorrow! See you at booth F21!

🌟 #Milestone - The #ECRAIDPrime NONS and saline nasal spray study has concluded, marking the completion of a key phase in evaluating treatments for #respiratoryinfections in the community, and proof-of-concept for accelerating clinical research response to outbreaks. 👉🏼 ecraid.eu/news/ecraid-...

Last Call to register! 🔔 Join the PrIMAVeRa Stakeholder Meeting & Live hashtag#AMR Dashboard Demo in Munich! 📅 Sunday, 19 April 2026 🕛 12:00 – 15:00 (CEST) 📍 H4 Hotel München Messe (5 mins’ walk from ESCMID venue) Limited spots available! 📩 Interested? Send an email to [email protected].

Ecraid has joined the BEAM Alliance, reinforcing our commitment to tackling antimicrobial resistance. By contributing our clinical research expertise and network, we aim to better connect innovation with real-world needs & help shape future AMR solutions in Europe. 👉🏽Read more: bit.ly/BeamAlliance

📣 Arjan van Manen joins us as Head of Business Development. With 20+ years in clinical strategy, he’s focused on closing the gap between clinical need & investment risk. 🤝🏽 Understanding challenges to deliver data-driven, tailored solutions. 📍At ESCMID? Connect with him! 🔗https://bit.ly/ArjanEcraid

📝 Have insights on ethical review procedures for cohort studies? Participate in this survey (15–20 min) to help improve the efficiency of ethical review processes for cohort studies during public health emergencies. www.id-care.net/post/share-y...

📣 Our March newsletter is out! 🔬 Join us at #ESCMIDGlobal2026 in Munich (Booth F21) 🎓 5th Young Investigator Workshop – 19 April, 09:30 CEST 🏥 ECRAID-Prime trial advances patient-centric research Plus new publications & collaborations. 👉🏽Subscribe now: mailchi.mp/ecraid/newsl...

Join the Young Investigator Workshop at #ESCMIDGlobal 2026 for practical insights and science you can actually use! Early-career investigators are driven to deliver meaningful research, but navigating the “how” isn’t always straightforward. 📍 Room 2 (ICM Ground Floor) 👉 bit.ly/4uKdN0r

Looking ahead to #ESCMIDGlobal 2026 in Munich, we’re reflecting on the energy & collaboration from Vienna last year. Great to connect with so many experts & partners advancing ID research. Excited to continue these conversations in Munich. Will you be there? Visit us at booth F21: bit.ly/474r0qy

📢Ecraid has joined the WHO Global Clinical Trials Forum. This milestone boosts our mission to advance high-quality research, strengthen global collaboration, and improve trial readiness, data sharing, and patient outcomes worldwide. Read more: bit.ly/418YDEh #GlobalHealth @whowpro.bsky.social

A recent article published in Contemporary Clinical Trial Communications evaluates the considerations raised during the regulatory & ethics review of five ID #PlatformTrials: #ECRAIDPrime, #RECLAIM, #REMAPCAP, #RECOVERY, and #SNAP. Explore the full article here bit.ly/4v0qSCH #TrialInnovation

📍Visit us at booth #F21 at #ESCMID Global 2026 in Munich! Innovation in ID requires strong partnerships. 🔬At Ecraid we're committed to building & growing collaborations across Europe to strengthen clinical research & tackle AMR. Meet our team & explore how we can work together: bit.ly/474r0qy

Two new #ECRAIDBase publications available! 🫁 The first provides a detailed narrative of the POS-VAP study. 📊 The second asks how do we measure knowledge, attitudes, & practices around biomedical data reuse? Explore the papers bit.ly/4beBA0z #ClinicalTrials #VAP #DataScience #CriticalCare

Will you be at #ESCMIDGlobal 2026 in Munich? Visit Ecraid at booth F21. As AMR and emerging infections continue to challenge healthcare systems, collaboration across academia, clinical networks & industry is essential. Interested in connecting? Book a meeting: bit.ly/474r0qy #InfectiousDiseases

The world of #ClinicalResearch is evolving fast - are you ready to grow with it? Join our 5th Young Investigator Workshop at #ESCMIDGlobal2026. A dedicated space for early-career researchers to gain practical, real-world insights you won't find in textbooks: bit.ly/4uKdN0r @escmid.bsky.social

At the AMR Conference in Basel, Ecraid announced a new partnership with @incate.bsky.social. Together we’re connecting clinical research & translational innovation to accelerate antimicrobial development & strengthen the pipeline against #AMR. Read how we combine our strengths: bit.ly/INCATE-Ecraid

Last Friday, @christophercbutler.bsky.social presented at the #RethinkingClinicalTrials webinar (hosted by @dcrinews.bsky.social and @pctcollaboratory.bsky.social). He highlighted pre-pandemic studies & how ECRAID-Prime & ECRAID-Base are strengthening #Europe’s response to future health threats.

🫱🏼‍🫲🏻 We're proud to present the #PrIMAVeRaProject and our #perpetualobervationalstudies at the 7th @amr-accelerator.bsky.social Cross-Project Meeting held in Basel yesterday. We look forward to seeing everyone again at the PrIMAVeRa stakeholder meeting at #ESCMID2026! @elskesieswerda.bsky.social

What if, in the next infectious disease outbreak, patients are: 🤒 Too sick to travel? 🦠 Unable to visit clinics & traditional research sites? 🏔️ Living in remote or underserved areas? The #ECRAIDPrime trial demonstrates that research does not need to stop. Trials can come to the patient.

New collaboration! We’re proud to announce that Ecraid has officially partnered with INCATE. We will play a key role in supporting, educating & guiding early-stage translational projects, strengthening their path toward successful development of new treatment modalities to combat #AMR.

See you at #ESCMIDGlobal2026 in Munich! 🇩🇪 Find us in the Exhibition Hall (Booth F21), and throughout the scientific programme. Our committed colleagues will present Ecraid-driven science in posters, presentations and talks during the congress. More details soon! @escmid.bsky.social

📢 Meet us at the AMR Conference in Basel! Our CEO @lenniederde.bsky.social & Head of BD Arjan van Manen will be attending. Ecraid is looking forward to discuss future collaborations with you! 📅 Book a meeting with us via the PartneringOne platform: lnkd.in/edKBRYf

Ecraid’s second newsletter of the year is out! Discover the latest updates, studies, publications & upcoming events! Inside this edition: 🔍Highlights from the Ecraid Foundation Science Meeting 🚀The launch of BE READY NOW And much more... 👉🏽Stay informed, subscribe now: bit.ly/EcraidNewsFe...

📢 Meet us at the AMR Conference in Basel! Our CEO @lenniederde.bsky.social & Head of BD Arjan van Manen will be attending. Ecraid is looking forward to discuss future collaborations with you! 📅 Book a meeting with us via the PartneringOne platform: lnkd.in/edKBRYf

🇪🇺 Our recent CoMeCT project Sustainability Workshop discussed the future development of the project’s coordination activities and its role in #BEREADY project to strengthen #clinicalresearch readiness for #publichealth emergencies. Read more on 👉🏽 www.ecraid.eu/news/coordin...

Lennie Derde speaks about #PandemicPreparedness in @horizoneu.bsky.social Magazine She explains the importance of a permanent clinical research infrastructure across Europe to tackle emerging #InfectiousDiseases & #AntimicrobialResistance projects.research-and-innovation.ec.europa.eu/en/horizon-m...

The BE READY NOW European Partnership is live! 🚀 Ecraid is supporting this initiative by building 'ever-warm' research networks & FAIR data protocols, ensuring Europe is ready to respond to threats with unprecedented speed. 🔗 Full details bit.ly/463tpBe #PandemicPreparedness #ClinicalResearch